Clinical Trial Update: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial [Phase 2]

View source ↗

Summary

This document describes a Phase II trial (RAPS) evaluating Response Adaptive Ablative Pre-operative SPBI with non-operative sentinel lymph node biopsy for early…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING